Compare Abbott Laboratories (ABT) vs Rush Street Interactive Inc (RSI) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abbott Laboratories vs Rush Street Interactive Inc — how do they compare? Abbott Laboratories trades at $95.6 (market cap $166.94B), while Rush Street Interactive Inc trades at $32.29 (market cap $3.33B). The key difference: Abbott Laboratories is far larger — about 50.1× Rush Street Interactive Inc's market cap, and Abbott Laboratories pays a 2.63% dividend while Rush Street Interactive Inc pays none. Which is the better fit depends on your goals.
| ABT | RSI | |
|---|---|---|
Market Cap | $166.94B | $3.33B |
Sector | Health | Technology |
52-Week High | $136.62 | $32.31 |
52-Week Low | $82.57 | $14.51 |
Enterprise Value | $193.69B | $3.00B |
Dividend Yield | 2.63% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
RSI trades at $32.22, up 1.7% on the day, with strong technical momentum and bullish moving averages. The company reported Q1 2026 EPS of $0.14, beating estimates, and revenue growth to $1.13B in 2025. Analyst consensus is a Buy with a $29.11 target, though high P/E of 94.76 signals premium valuation. Recent news highlights operational strength and a $100M share repurchase program.
Outlook is positive given earnings beats and sector tailwinds, but risks include elevated valuation and competitive pressures. Net income margin of 2.98% remains thin, requiring sustained growth to justify multiples. Institutional sentiment is bullish, with 10 Buy ratings, supporting near-term upside if execution continues.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →About Rush Street Interactive Inc
Rush Street Interactive, Inc. is a digital gaming and sports betting company operating in the regulated U.S. and international markets. The company owns and operates online casino (iGaming) and sports wagering platforms, including BetRivers and PlaySugarHouse brands. RSI focuses on providing a secure and high-quality online gaming experience, leveraging its proprietary technology platform and commitment to responsible gaming.
Read more on RSI →
